QianfoshanH
Shandong, China
NCT Number: NCT06025461
Objective: To explore the potential association between the multimodal ultrasound characteristics and pathological classification of BI-RADS category 4 breast lesions, so as to clarify the diagnostic characteristics of multimodal ultrasound in different pathological types BI-RADS category 4 breast lesions.
Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.
Looking for future studies?
Notify Me30 year–76 year
Female
Observational
Shandong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no intervention
Time frame: Immediately record the elastic modulus value after the patient receives routine ultrasound and shear wave elastography
The ratio of lesion length on strain elastography images to lesion length on grayscale images
Time frame: Immediately record the elastic modulus value after the patient receives routine ultrasound and shear wave elastography
Shear wave velocity values at the hardest point of the lesion and surrounding tissues
Time frame: Immediately record the elastic modulus value after the patient receives routine ultrasound and shear wave elastography
The ratio of average strain between surrounding tissues at the same depth and the lesion
Ma Zhe
Other
Correlation Between Multi-modal Ultrasound Features and Pathologic Classification of BI-RADS Category 4 Breast Lesions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05343975
Breast Disease, Breast Diseases
Angers, France
View Trial DetailsNCT06886659
Antineoplastic Agents, Breast Cancer
Dhaka, Bangladesh
View Trial DetailsNCT00639535
Breast Disease, Breast Diseases
Liverpool, New York, United States
View Trial DetailsNCT06026176
Breast Disease, Breast Diseases
Dharān, Koshi, Nepal
View Trial Details